Herpes Simplex Virus Shedding Rate: Surrogate Outcome for Genital Herpes Recurrence Frequency and Lesion Rates, and Phase 2 Clinical Trials End Point for Evaluating Efficacy of Antivirals

BACKGROUND: We tested whether genital herpes simplex virus (HSV) shedding is an appropriate surrogate outcome for the clinical outcome of genital herpes lesions in studies of HSV-2 antiviral interventions. METHODS: We analyzed prospective data from natural history studies and clinical trials of anti...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Infect Dis
Autores principales: Agyemang, Elfriede, Magaret, Amalia S, Selke, Stacy, Johnston, Christine, Corey, Larry, Wald, Anna
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2018
Materias:
Major Articles and Brief Reports
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6195656/
https://ncbi.nlm.nih.gov/pubmed/30020484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiy372
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares